Clinical Distribution and Drug Susceptibility Characterization of Invasive Candida Isolates in a Tertiary Hospital of Xinjiang Province
Songdi Zhang,Lijuan Zhang,Aikedai Yusufu,Hadiliya Hasimu,Xiaodong Wang,Paride Abliz
DOI: https://doi.org/10.2147/idr.s450933
2024-04-05
Infection and Drug Resistance
Abstract:Songdi Zhang, &ast Lijuan Zhang, &ast Aikedai Yusufu, &ast Hadiliya Hasimu, Xiaodong Wang, Paride Abliz Department of Dermatology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaodong Wang; Paride Abliz, Department of Dermatology, The First Affiliated Hospital of Xinjiang Medical University, No. 393, Xinyi Road, Urumqi, Xinjiang, People's Republic of China, Email ; Objective: This study aims to investigate the clinical distribution characteristics and drug susceptibility profiles of invasive Candida isolates in a tertiary hospital in Urumqi. Methods: The examination was conducted on samples obtained from patients who were clinically diagnosed with invasive candidiasis in this hospital. A total of 109 strains of Candida strains were identified through the use of internal transcribed spacer (ITS) sequencing and fungal cultivation methods.The clinical distribution of the strains was analyzed. Antifungal drug susceptibility tests were performed using the Sensititre YO10 fungal drug susceptibility plate based on the micro-broth dilution method. Results: Candida albicans had the highest percentage (51.38%) among 109 Candida isolates, followed by C. glabrata (18.35%) and C. tropicalis (15.60%). The isolates were predominantly found in the respiratory department (41.28%), intensive care unit (ICU) (31.19%), and infection department (9.17%).The results of drug susceptibility tests indicated that amphotericin B, 5-fluorocytosine, and echinocandins exhibited good in vitro antifungal activity, with a susceptibility rate of over 96%. However, the azoles demonstrated low antifungal activity, especially posaconazole and voriconazole, which had high resistance rates of 64.71% for C. tropicalis and 70% for C. glabrata , respectively. Conclusion: In our hospital, Candida albicans was identified as the primary causal agent of invasive candidiasis. In terms of in vitro antifungal activity, echinocandins, amphotericin B, and 5-fluorocytosine demonstrated efficacy against invasive Candida infections. However, it was important to note that C. glabrata and C. tropicalis exhibited low susceptibility to azoles. Keywords: Candida isolates, clinical distribution, antifungal drug susceptibility tests, drug resistance Graphical The incidence of invasive fungal infections is increasing, attributed to the wide usage of glucocorticoids, broad-spectrum antibiotics, immunosuppressants, as well as advances in invasive manipulation techniques and novel therapeutic approaches. 1,2 Among these infections, invasive candidiasis is the most common, with Candida albicans being the predominant causative agent; however, due to the widespread use of antifungal medications, there is an epidemiological shift in the prevalence of strains from Candida albicans to non- Candida albicans Candida species (NCAC). 3 The epidemiology and drug sensitivity of invasive Candida strains vary based on different regions, patients, and doctors' medication practices.Understanding the local distribution of strains and their drug susceptibility brings numerous advantages in terms of prompt detection and therapy, thereby improving the cure rate and reducing drug resistance and adverse reactions caused by long-term empiric and preventive use of antifungal drugs. This research aimed to analyze the distribution of Candida strains obtained from patients with invasive candidiasis within a prominent tertiary care hospital situated in Urumqi, the capital city of Xinjiang Province. Furthermore, we evaluated the characteristics of drug resistance to establish a credible scientific foundation for improving the diagnosis and treatment strategies for invasive Candida infections in the local area. Samples were obtained from the respiratory tract, digestive tract and other parts of patients who were clinically diagnosed with invasive candidiasis in all the wards in the First Affiliated Hospital of Xinjiang Medical University from June 2022 to June 2023. A total of 109 Candida strains were detected, ensuring that any replication of strains from a single patient was excluded. The identification of strains involved the use of Candida chromogenic media (CHROMagar, France) for morphological identification and ITS sequencing for molecular biological identification.DNA samples from Candida strains were PCR amplified using fungal universal primers ITS1/ITS4.ITS 1:5'-TCCGTAGGTGAACCTGCGG-3', ITS4:5'-TCCTCCGCTT -Abstract Truncated-
pharmacology & pharmacy,infectious diseases